KNAW

Back to search results
Person

Prof.dr. G.J. Ossenkoppele

Pagina-navigatie:


Update Persondata


Expertise Therapy of haematological malignancies; Stam cell transplantation; AML, NHL MDS, CMC, M.Hodgkin; Multiple myeloma; Immune therapy;Hemato-oncology; High dose therapy; immune therapy; Minimal residual disease
Expertise (NL) Therapie van maligne hematologische ziekten; stamcel transplantatie; AML, NHL, MDS, M. Hodgkin, M. Kahler, CMC; Immunotherapie;Hemato-oncologie: stamceltransplantatie en high dose therapie; Minimaal residuale ziekte; MDS, NHC
Addition Lid HOVON; Lid CUVO

Active as

Professor
Organisation Department of Hematology (VU)
Chair (EN) Translational hematology
Chair (NL) Translationele hematologie
Phone +31-20-4442604
Email g. ossenkoppele -at- vumc. nl
URL http://www.hematologie.nl

Current research

(the most recent research is at the top)
Project leader Discontinuation of imatinib in CML patients in continuous complete molecular remission
Project leader Tailoring of (immune-)therapy in R-CHOP refractory diffuse large B-cell lymphoma (DLBCL) patients
Project leader Role of signal transduction pathways and the microenvironment in the emergence of minimal residual disease in acute myeloid leukemia
Project leader Detection and eradication of minimal residual disease (MRD) in AML
Project leader Detection of residual leukemic stem cells during minimal residual disease in acute myeloid leukemia
All current research..

Completed research projects

(the most recent research is at the top)
Project leader Identification of targeted therapies for anaplastic large cell lymphoma based on apoptosis expression profiles
Project leader Optimizing strategies in dendritic cell vaccination in myeloid leukaemia
Project leader Targeted therapy in hematological malignancies: Antibody-targeting, erythropoietin and granulocyte-colony stimulating factor, farnesyl protein transferase and tyrosine kinase inhibitors.
Supervisor Identification and characterization of acute myeloid leukemia stem cells
Researcher Implementation of minimal residual disease assessment using multicolour flow cytometry in multicenter clinical studies in acute myeloid leukemia
All completed research..

Classification

A70000 Public health and health care
D23120 Oncology
D23221 Blood and lymphatic diseases

Go to page top
Go back to contents
Go back to site navigation